Who owns Axsome Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AXSM from SEC Form 13F filings across 465 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 465 institutions disclosed 40.1M shares of Axsome Therapeutics, Inc. worth $7.36B — about 76.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
465
13F holders
$7.36B
value, 2026 filers
76.4%
of shares outstanding (40.1M sh)
67
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AXSM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.5M | $636.5M | 0.0% | 6.6% | +11.2% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $370.1M | 0.0% | 3.8% | +2.1% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $363.7M | 0.0% | 3.8% | -0.5% |
| 4 | Invesco Ltd. | 1.9M | $355.9M | 0.0% | 3.7% | +15.5% |
| 5 | FMR LLC | 1.4M | $266.3M | 0.0% | 2.8% | -6.2% |
| 6 | MILLENNIUM MANAGEMENT LLC | 1.3M | $244.0M | 0.1% | 2.5% | +137.9% |
| 7 | TWO SIGMA INVESTMENTS, LP | 1.1M | $204.8M | 0.1% | 2.1% | +65.9% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $186.3M | 0.0% | 1.9% | +4.5% |
| 9 | UBS Group AG | 849,766 | $156.7M | 0.0% | 1.6% | +459.4% |
| 10 | STATE STREET CORP | 823,330 | $151.8M | 0.0% | 1.6% | +4.8% |
| 11 | Deep Track Capital, LP | 800,000 | $147.5M | 2.4% | 1.5% | +14.3% |
| 12 | FRANKLIN TEMPLETON INC | 746,254 | $102.2M | 0.0% | 1.4% | +11.7% |
| 13 | BANK OF AMERICA CORP /DE/ | 740,718 | $136.6M | 0.0% | 1.4% | +63.7% |
| 14 | WESTFIELD CAPITAL MANAGEMENT CO LP | 725,608 | $133.8M | 0.4% | 1.4% | +399.9% |
| 15 | PRICE T ROWE ASSOCIATES INC /MD/ | 666,790 | $123.0M | 0.0% | 1.3% | +3.7% |
| 16 | ALETHEA CAPITAL MANAGEMENT, LLC | 649,117 | $119.7M | 60.9% | 1.2% | +0.1% |
| 17 | D. E. Shaw & Co., Inc. | 630,992 | $116.3M | 0.1% | 1.2% | +4.3% |
| 18 | AMERIPRISE FINANCIAL INC | 614,222 | $113.3M | 0.0% | 1.2% | +43.5% |
| 19 | MORGAN STANLEY | 591,504 | $109.1M | 0.0% | 1.1% | -26.4% |
| 20 | AQR CAPITAL MANAGEMENT LLC | 561,497 | $103.5M | 0.0% | 1.1% | +392.4% |
| 21 | FIRST TRUST ADVISORS LP | 552,720 | $101.9M | 0.1% | 1.1% | +14.7% |
| 22 | WELLINGTON MANAGEMENT GROUP LLP | 493,207 | $90.9M | 0.0% | 0.9% | -24.6% |
| 23 | FEDERATED HERMES, INC. | 482,338 | $88.9M | 0.1% | 0.9% | +171.2% |
| 24 | Pictet Asset Management Holding SA | 481,524 | $88.8M | 0.1% | 0.9% | +12.9% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 476,450 | $87.9M | 0.0% | 0.9% | +50.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.